LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
+69.04%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$500M
AUM Growth
+$500M
(+92%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
43.68%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
72
New
32
Increased
7
Reduced
5
Closed
26
Top Buys
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$59.5M |
| 2 |
Celldex Therapeutics
CLDX
|
$26M |
| 3 |
Avidity Biosciences
RNA
|
$25.6M |
| 4 |
Repare Therapeutics
RPTX
|
$20.3M |
| 5 |
BioNTech
BNTX
|
$19.7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$20.2M |
| 2 |
Sarepta Therapeutics
SRPT
|
$18.3M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$14.1M |
| 4 |
Moderna
MRNA
|
$13.8M |
| 5 |
Ascendis Pharma
ASND
|
$13.5M |
Sector Composition
| 1 | Healthcare | 94.66% |
